A survey of perioperative management of sickle cell disease in North America

Paediatric Anaesthesia

Volumn 21, Issue 1, 2011, Pages 43-49

  Firth, Paul G ^a   McMillan, Kristen N ^b   Haberkern, Charles M ^c   Yaster, Myron ^b   Bender, Michael A ^c   Goodwin, Salvatore R ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d MAYO CLINIC   (United States)

Author keywords

acute chest syndrome; anesthesia; hemoglobinopathy; pain crisis; sickle cell disease; surgery

Indexed keywords

INFUSION FLUID;

ARTICLE; BLOOD TRANSFUSION; CHILD; CHILD HEALTH CARE; CLINICAL PRACTICE; DISEASE EXACERBATION; DISEASE SEVERITY; FLUID RESUSCITATION; HEALTH CARE SURVEY; HEMOGLOBIN DETERMINATION; HOSPITALIZED CHILD; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MINIMALLY INVASIVE PROCEDURE; NORTH AMERICA; PEDIATRICIAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA;

EID: 78650335172     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2010.03415.x     Document Type: Article

References (24)

1. Neel JV,. The inheritance of sickle cell anemia. Science 1949; 110: 64-66.
2. Pauling L, Itano HA, Singer SG, et al. Sickle cell anemia, a molecular disease. Science 1949; 110: 543-548.
3. Marotta CA, Forget BG, Cohne-Solal M, et al. Human beta-globin messenger RNA. I. Nucleotide sequences derived from complementary RNA. J Biol Chem 1977; 252: 5019-5031.
4. Ingram VM,. A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin. Nature 1956; 178: 792-794.
5. Ingram VM,. Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature 1957; 180: 326-328.
6. Asakura T, Onishi T, Friedman S, et al. Abnormal precipitation of oxyhemoglobin S by mechanical shaking. Proc Natl Acad Sci USA 1974; 71: 1594-1598.
7. Roth EF Jr, Elbaum D, Bookchin RM, et al. The conformational requirements for the mechanical precipitation of hemoglobin S and other mutants. Blood 1976; 48: 265-271.
8. Lancaster JR Jr,. Reaping of nitric oxide by sickle cell disease. Proc Natl Acad Sci USA 2002; 99: 552-553.
9. Robinson JM, Lancaster JR Jr,. Hemoglobin-mediated, hypoxia-induced vasodilation via nitric oxide: mechanism(s) and physiologic versus pathophysiologic relevance. Am J Respir Cell Mol Biol 2005; 32: 257-261.
10. McMahon TJ, Doctor A,. Extrapulmonary effects of inhaled nitric oxide: role of reversible S-nitrosylation of erythrocytic hemoglobin. Proc Am Thorac Soc 2006; 3: 153-160.
11. Koshy M, Weiner SJ, Miller ST, et al. Surgery and anesthesia in sickle cell disease. Cooperative study of sickle cell diseases. Blood 1995; 86: 3676-3684.
12. Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med 1995; 333: 206-213.
13. Haberkern CM, Neumayr LD, Orringer EP, et al. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group. Blood 1997; 89: 1533-1542.
14. US National Institutes of Health. The Management of Sickle Cell Disease (NIH Pub. No. 04-2117), 4th edn. Bethesda, MD, National Institutes of Health, 2002, pp 2006.
15. Firth PG, Head CA,. Sickle cell disease and anesthesia. Anesthesiology 2004; 101: 766-785.
16. Firth PG,. Anaesthesia for peculiar cells-a century of sickle cell disease. Br J Anaesth 2005; 95: 287-299.
17. Goodwin SR, Haberkern C, Crawford M, et al. Sickle cell and anesthesia: do not abandon well-established practices without evidence. Anesthesiology 2005; 103: 205, author reply 205-207.
18. Firth PG,. Pulmonary complications of sickle cell disease. N Engl J Med 2009; 360: 1044 author reply 1044-1045.
19. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991; 325: 11-16.
20. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639-1644.
21. Kinney TR, Sleeper LA, Wang WC, et al. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The cooperative study of sickle cell disease. Pediatrics 1999; 103: 640-645.
22. Buck J, Casbard A, Llewelyn C, et al. Preoperative transfusion in sickle cell disease: a survey of practice in England. Eur J Haematol 2005; 75: 14-21.
23. Hseih MM, Kang EM, Fitzhugh CD, et al. Allergenic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med 2009; 361: 2309-2317.
24. Dew A, Van Besien K,. Stem-cell transplantation for sickle cell disease. N Engl J Med 2009; 362: 955.